The application of minimally-invasive interventional technique in the clinical treatment of symptomatic polycystic liver disease and its recent advances
10.3969/j.issn.1008-794X.2024.02.020
- VernacularTitle:微创介入技术治疗症状性多囊肝的临床应用及进展
- Author:
Yining LIANG
1
;
Zhenhua DU
;
Zhilong WANG
;
Taiyang ZUO
Author Information
1. 250013 山东济南 山东第一医科大学
- Keywords:
symptomatic polycystic liver disease;
percutaneous cyst sclerotherapy;
transcatheter arterial embolization
- From:
Journal of Interventional Radiology
2024;33(2):208-212
- CountryChina
- Language:Chinese
-
Abstract:
Clinically,polycystic liver disease(PLD)is a rare genetic disease.Most patients have no clinical symptoms,and a few patients with symptomatic PLD complicated by serious complications need to be treated.Liver transplantation is the only radical treatment for patients with symptomatic PLD.However,most patients are not able to receive liver transplantation due to a lack of donors,expensive surgical cost,and high risk.Because of its many advantages such as less trauma,fast recovery,repeatable,high safety and fewer complications,the minimally-invasive interventional techniques,represented by percutaneous cyst sclerotherapy and transcatheter arterial embolization,have been successfully employed for the treatment of symptomatic PLD in recent years,moreover,its clinical effect has been recognized by both doctors and patients.Therefore,as it can improve the local symptoms and the quality of life of patients,the therapy using minimally-invasive interventional technique will become the development direction for the treatment of symptomatic PLD.This article aims to make a comprehensive review concerning the principle,mechanism,guiding mode,clinical application,advantages and disadvantages,and related complications of percutaneous cyst sclerotherapy and transcatheter arterial embolization therapy in the treatment of symptomatic PLD.
